ACR Appropriateness Criteria® female breast cancer screening: 2023 update Guidelines
| Authors: | Niell, B. L.; Jochelson, M. S.; Amir, T.; Brown, A.; Adamson, M.; Baron, P.; Bennett, D. L.; Chetlen, A.; Dayaratna, S.; Freer, P. E.; Ivansco, L. K.; Klein, K. A.; Malak, S. F.; Mehta, T. S.; Moy, L.; Neal, C. H.; Newell, M. S.; Richman, I. B.; Schonberg, M.; Small, W. Jr; Ulaner, G. A.; Slanetz, P. J. |
| Title: | ACR Appropriateness Criteria® female breast cancer screening: 2023 update |
| Abstract: | Early detection of breast cancer from regular screening substantially reduces breast cancer mortality and morbidity. Multiple different imaging modalities may be used to screen for breast cancer. Screening recommendations differ based on an individual's risk of developing breast cancer. Numerous factors contribute to breast cancer risk, which is frequently divided into three major categories: average, intermediate, and high risk. For patients assigned female at birth with native breast tissue, mammography and digital breast tomosynthesis are the recommended method for breast cancer screening in all risk categories. In addition to the recommendation of mammography and digital breast tomosynthesis in high-risk patients, screening with breast MRI is recommended. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation. © 2024 American College of Radiology |
| Keywords: | adult; aged; cancer diagnosis; breast cancer; echomammography; evidence based practice; cancer screening; high risk patient; mammography; contrast enhancement; methoxy isobutyl isonitrile technetium tc 99m; contrast medium; clinical practice guideline; cancer classification; breast mri; breast magnetic resonance imaging; intermediate risk patient; breast cancer screening; appropriateness criteria; breast density; auc; human; female; article; appropriate use criteria; breast tissue; digital breast tomosynthesis; female breast cancer screening |
| Journal Title: | Journal of the American College of Radiology |
| Volume: | 21 |
| Issue: | 6 Suppl. |
| ISSN: | 1546-1440 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2024-06-01 |
| Start Page: | S126 |
| End Page: | S143 |
| Language: | English |
| DOI: | 10.1016/j.jacr.2024.02.019 |
| PROVIDER: | scopus |
| PUBMED: | 38823941 |
| DOI/URL: | |
| Notes: | Article -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work